HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


COVID-19 Mentions Prohibited From Supplement Ads - UK Regulator

Executive Summary

Dietary supplement ads should not make any explicit or implicit references to COVID-19, with immunity boosting claims also strictly off limits, says UK regulator the Advertising Standards Authority.

You may also be interested in...

UK Vibrating Device Marketer Unshaken By Regulatory Action Against COVID-19 Claims

Psychologist Anthony Grant operates “Resonator.UK” and sells a device that vibrates on the 30kHz frequency at 30,000 times a second. Claims including “the only safe way to destroy a virus is to shake it to pieces” challenged by MHRA and consumers.

France Puts The Brakes On Launch Of Anti-COVID Nasal Spray

COV-Defense nasal spray, claimed to inactivate the SARS-CoV-2 virus, will no longer launch in France after regulator ANSM demanded rigorous efficacy and safety data.

ASA Not Sweet On Cough Claims For Honey

There are no circumstances when a food can claim to treat human disease, even when this goes against public health guidance, rules the UK's Advertising Standards Authority in case brought against a New Zealand-based manuka honey company.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts